Objective: Care for demented people is very resource demanding, the prevalence is increasing and there is so far no cure.
Introduction
Dementia disorders are chronic, progressive, long lasting and, so far, uncurable. Despite the profound impact on patients and their immediate families, the combination of expensive formal care services, a great and increasing number of affected people, and a major reliance on informal care provided by family members dialogue between these actors to identify ways of developing synergies and closer collaboration at a European level. This network would also respond to the objectives of the Community Action Programme concerning the creation of a sustainable health monitoring and information system for Alzheimer's disease and other forms of dementia. One part of the project was to highlight the socio-economic impact of dementia in the EU. In doing so, it was considered important to stress the fact that the societal costs of dementia fall not only on the medical sector but also impact on social care services and place demands on the time of informal unpaid carers. Although frequently used in policy-making discussions, Cost of illness (CoI) studies cannot directly be used for cost effectiveness/priority decisions. They can however be used to identify the distribution of socio-economic costs between different contributors to the care-giving process and by analysing differences between regions/ countries and changes over time; CoI studies can provide valuable data for such discussions.
Aim
Based on the work in Eurocode (Wimo et al., 2008; Eurocode, 2009a; Eurocode, 2009b) , the aim of this paper is to describe the economic impact of dementia in Europe in 2008. The principal focus will be on the European Union (EU27) but costs for the European Economic Area and some candidate countries, as well as different regions of Europe, will also be highlighted.
Methods

Prevalence
The age specific prevalence figures used in the main CoI estimates are based on a new meta analysis undertaken by the Eurocode group (Eurocode, 2009c) but other prevalence sources are presented in a sensitivity analysis. Because of uncertainties in the prevalence estimates below the age of 60, this paper is focused on dementia in those aged 60þ. Five-year age-class demographic statistics from the UN (United Nations, 2004) were combined with the age specific prevalence estimates.
Search strategies for the cost of illness estimates A literature review was conducted for papers reporting data on costs of care and amount and costs of informal care for patients with diagnosed dementia or possible/ probable Alzheimer's disease. The key criterium was that direct and informal care costs could be identified. By direct costs we mean costs of resources used in the medical (e.g. hospital care) and non-medical (e.g. home help, nursing home care) sectors. By informal care we mean the burden in terms of resource use and costs of caring for a demented person.
A general search was conducted in PubMed/Medline, Ingenta, Cochrane Library, NHSEED/HTA, HEED, EMBASE, Current contents, PsycINFO, ERIC, Societal services abstracts and Sociological abstracts. The search terms (MESH/Subheadings when appropriate) were dementia/Alzheimeŕs disease/Alzheimer disease combined with cost and/or economics and/or informal care. Two recent systematic reviews comprising published papers between 1969 and 2008 with at least an abstract in English were also included (SBU, 2008; Jönsson and Wimo, 2009 ). Many irrelevant abstracts and papers had already been removed by the work in the two systematic reviews (4234 initial hits including duplicates were identified in the SBU review (SBU, 2008) and 590 abstracts were identified in the European review ). When appropriate, handsearch in journals' reference lists was used. Additional search in the databases and knowledge of published reports of good quality resulted in another three reports.
The search resulted in papers with both a top-down and bottom-up approach to the estimation of costs. After exclusion of obvious irrelevant hits/abstracs by title and abstract reading, remaining abstracts and papers of interest were reviewed by two persons.
The cost model
Fourteen papers from 'key countries' were finally selected as eligible for the European cost model (Cavallo and Fattore, 1997; Koopmanschap et al., 1998; Schulenberg and Schulenberg, 1998; Kronborg Andersen et al., 1999; Trabucchi, 1999; Boada et al., 1999; O'Shea and O'Reilly, 2000; Scuvee-Moreau et al., 2002; Rigaud et al., 2003; Zencir et al., 2005; Jonsson et al., 2006; Knapp and Prince, 2007; Gulacsi et al., 2008; (Table 1 ). The costs of the single studies were converted to s2008 and adjusted for differences in purchasing power parity between countries using a method described elsewhere (AndlinSobocki et al., 2005) .
For countries where no CoI figures were available, imputation was used based on the direct costs and costs of informal care per demented person. The cost model is based on direct costs and informal care. Based on how care is presented in the 14 key country papers and the income level of the coutries, four care patterns were identified and used for the imputation representing the relationship between formal care (direct costs) and informal care in northern (mainly formal care, high income), western (mix between formal and informal care, high income), southern (mainly informal care, high income) and eastern Europe (mainly informal care, low income) (Esping-Andersen, 1990; Burlacu, 2007) . These patterns fitted rather well with the UŃ s region classification of Europe, which is used for the regional results presentation (see Appendix 1 for country classification but for Estonia, Latvia and Lithuania imputation patterns for eastern Europe were used). From macro-economic research it is well known that there is a strong correlation between expenditures on health care per capita and the Gross Domestic Product (GDP) per capita (Håkansson, 1998; Gerdtham and Lothgren, 2000) . Since there are differences in economic status between countries, the imputed figures were adjusted for differences in GDP based on purchasing-power-parity (PPP) per capita between countries (IMF, 2008) . In the base case, the GDP adjustments versus a GDP index were made for the EU. 
The viewpoint
A health economic analysis can be presented from different viewpoints. With a societal perspective all relevant costs (direct medical and non-medical costs within the health and social care sectors and indirect costs due to production losses and costs of informal care) and outcomes are included (Drummond et al., 2004) . However, the analysis can also be done from a specific payer's point of view such as the public purse, a municipality or county council, an insurance company, caregiver or patient (the latter corresponding to 'out of pocket costs'). Depending on the chosen perspective, the results of the analysis are different. Crucial in any health economic analysis is transparency regarding the viewpoint adopted. Since the underlying CoI papers include both direct medical and nonmedical costs, as well as indirect costs in terms of informal care, we regard the viewpoint as societal. The indirect costs of persons with dementia are not included since most of them are retired and thus these costs are very low. We did not seek to provide a breakdown of direct costs given differences in the boundaries between health and social care services in the different countries.
The CoI arising from dementia are presented for three different areas:
(1) the EU27; (2) the EU27 plus candidate countries (Croatia, the Former Yugoslav Republic of Macedonia and Turkey), plus countries in the European Economic Area (EEA -Norway, Iceland, Liechtenstein) and Switzerland (EUþ); (3) and the whole of Europe and its regions defined according to the United Nations (UN) classification (UN, 2009), except that Cyprus as a member of EU and Turkey as a candidate country for EU were included (these countries are included with western Asia by the UN definition). We did not include Armenia, Azerbaijan and Georgia, since these countries are defined as being in western Asia by the UN and have no links to EU. The Vatican state, San Marino, Monaco and Andorra were excluded due to their small populations.
Sensitivity analysis
In the base case scenario, the new Eurocode age specific prevalence figures for dementia were used. These figures resulted in a greater number of demented people, particularly women. We made use of other prevalence estimates in sensitivity analysis: Eurodem Lobo et al. (2000) . Different alternatives for GDP adjustments and imputation were also tested. In the base case, the GDP adjustments were made versus the whole EU while in the sensitivity analysis the adjustments were made versus the regional subdivision. In another option the region specific costs that were used for imputation were adjusted for the size of the dementia populations in the key countries. Finally, imputation was used for all countries (even in countries that had underlying data).
Ethics
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Results
It was estimated that there were about 7.23 million people with dementia in the EU27 in 2008. The corresponding figures for the extended EU was 7.82 millions and 10.11 for the whole of Europe. The total costs of illness for dementia disorders in the EU27 in 2008 were estimated to be s160 billion (Table 2) , of which 56% were attributed to the costs of informal care. The corresponding costs for the wider EU sphere (EEA, EU candidate countries and Switzerland) and for the whole Europe were s167 and s177 billion, respectively. Regional patterns in costs can be identified; direct costs, predominantly institutional care, are prominent in northern Europe while informal care remains the major cost component in southern Europe, a region where familial obligations to provide care remain the norm (Table 3 ). The cost per demented person was about s22 000 per year (Table 3) , while it was somewhat lower for the wider EU/EEA sphere and the whole of Europe. The total societal costs per case are estimated to be eight times more in our northern compared to eastern European cluster of countries. Our sensitivity analysis of different prevalence sources consistently indicated lower cost estimates, ranging from s111 billion in total in the EU27 when using the data from Lobo et al. to s135 billion using the Eurodem figures (Table 4 ). The different approaches for imputation and GDP-adjustments (Table 5) showed rather consistent results versus the base case except that the costs for eastern Europe were higher.
The correlations between the direct, informal care and total costs based on imputation and the costs from the key countries were 0.84, 0.93 and 0.91, respectively ( p ¼ 0.01, <0.001 and <0.001, respectively).
Discussion
There are of course 'true' differences in the CoI of dementia across Europe. The pattern of care and services varies from one country to another, depending on both national and/or regional policies both concerning the extent to which services are provided by the health or social care sectors and the extent to which funding structures and entitlements to services differ between these two sectors. Differences in monetary resources as well as in infrastructure, such as the availability of specialist workforce personnel and facilities, will also have an impact. As we have noted, differences in culture and legal structures may also have an impact; the onus on families to provide informal care remains strong in southern Europe. Moreover, in some countries or regions within countries, there may be specific legal obligations on family members to provide at least financial support for the care of a loved one with dementia. Thus, with given needs for care, the costs and the distribution of the costs between different care providers vary because the service systems vary from country to another. While it is clear that the socio-economic impacts of dementia in Europe are high, there are also methodological issues that need to be highlighted. The differences in the 14 included studies from different parts of Europe reflect different care patterns and care systems but also different costing approaches. The high direct cost per demented person from northern Europe is a result of high costs particularly in two studies from UK (Knapp and Prince, 2007) and Sweden (Wimo et al., 2007a) . On the other hand, the high costs of informal care in southern Europe reflect the greater reliance on the inputs of informal carers (here valued in terms of the costs that would be incurred by a professional carer if informal care was not provided), also illustrating the complex interaction between the medical and social care sectors as well as informal care. The input of informal care in terms of hours per day in the sources from southern Europe were high, relative to those in northern Europe, helping to explain the high costs of informal care. In the Italian study for example, the total amount of informal care was almost 13 h per day (Cavallo and Fattore, 1997) , which is more than twice as much as in a Swedish study (Nordberg et al., 2005) with the same care components included (ADLs and supervision). However the estimate of costs for eastern Europe remains weak. We could only identify one study from a country in this region-Hungary (which is part of the Eurocode project)-and the rather great range (although on a low level) of the eastern Europe estimates (Table 5) illustrates the problem.
Also with any given service system, the level, the nature and a cultural conceptualisation of individual need will have a large impact on costs. The need for medical services may appear straightforward: poor health is a state or condition that results in the use of medical resources. In the case of social care services, identifying need becomes more complicated: first, in many cases need is not an individual phenomenon, it also concerns a family, a group of people, or even a neighbourhood. Secondly, the need is often in every day parlance, or maybe even in research, defined in terms of the essential supports, such as the need for income redistribution through the provision of maintenance grants, rather than in terms of a welfare loss (need in this sense) in an individual's quality of life. Needs may not be well met by services that are available. A third special feature is the particularly important role in dementia that informal carers play in overcoming problems, potentiall reducing the need for intervention by professional social care services.
It is, however, important to recognise that there are both rewards and difficulties associated with informal caregiving; yet often, the positive aspects may be overlooked. This desire and willingness of family members to provide care can though mean that policy makers and other stakeholders are tempted to treat informal care as a 'free resource'. However, it can entail significant economic costs for individuals and society. Economic analysis is primarily concerned with the opportunity costs of caring; i.e. what could have been done if an individual had not been caring.
Caring for someone with dementia can sometimes be, literally, a 24-hour-a-day activity. While we have noted that the availability of family carers may reduce the need for professional support, carers will incur a loss of time (and hence a cost), which they could have used for work, or to pursue leisure activities. Individuals may become isolated from their social network of family and friends as the disease progresses and caregiving becomes a full-time occupation (Leinonen et al., 2001) . Evidence of high levels of distress and depression among carers of people with dementia can be seen in many studies of service users and in community surveys (Clipp and George, 1993; Livingston et al., 1996; Murray et al., 1999; Coen et al., 2002; Thomas et al., 2005) . They may also incur additional out-of-pocket expenses to support a loved-one financially. There can also be adverse impacts on their physical health, e.g. as a result of the strains of helping an individual to cope with essential activities of daily living.
However, because of methodological difficulties in estimating informal care costs, and often too narrow a focus solely on the health care system alone, the cost to family carers has often been ignored within economic analyses. In particular, identifying the best alternative use of time is not always easy, particularly if a family carer already has been responsible, to some extent, for an individual, e.g. a spousal carer already undertaking a range of activities that benefit the whole household. This has led to a considerable variation in estimates of the cost of caring with estimates for Alzheimer's Disease and other dementias ranging from 36 to 85 per cent of total costs in one review (McDaid, 2001) .
Another key issue here is the number of demented people being cared for in long term care, which is a heavy cost driver. Even if there are estimates of the proportion of those with dementia in long-term care, it is very difficult to get Europe-wide figures on the number of available beds in a comparable way. There is, however, support for the care patterns identified and imputation principles used in this study in an Organisation for Economic Co-operation and Development (OECD) report on the costs of long term care and the association with GDP (OECD, 2006) , where the same northern and southern Europe costing patterns were observed. Western and European countries both lay between the Northern and Southern country clusters.
In an 'ideal', or at least improved, CoI study, representative information about resource utilisation should be collected in the same way during the same year in all countries, allowing better identification and valuation of different elements of cost. Furthermore, it should be possible to identify the contribution of dementia versus other disorders ('net costs') and to use similar principles for costing. Suprisingly, despite the profound personal and socio-economic impact of dementia, coupled with ever aging populations in almost all of Europe, we still do not have such data available. One major problem, as indicated by our reliance on imputation, is the lack of high quality data from eastern Europe; obtaining more epidemiological and resource use information from these countries must be a high priority. This is not only needed for CoI estimates, but also to allow for better service planning for people with dementia in this part of Europe.
We have noted that other cost estimates for Europe have shown lower costs per demented person than in our study. In studies making use of the Dementia Worldwide Cost Database (DWCD) (Wimo et al., 2007b; Wimo et al., 2010 ) the annual comparable European costs (adjusted to 2008 prices) were an average of s12 000 and s14 000, respectively per person with dementia compared with our estimate of more than s17 500. Estimates prepared by The European Brain Council (EBC) (Jonsson and Berr, 2005) were even lower at s11 700 (Andlin-Sobocki et al., 2005) . However, differences in the definition of Europe, criteria for study selection and methodological issues make direct comparisons problematic.
Nonetheless, despite these variations and methodological limitations, the societal costs of dementia in Europe are clearly very high and have a great impact of the social and health care systems in all countries.
With respect to difficulties in comparing different CoI studies (Wimo, 2010) , the societal costs of dementia are indeed high as compared to other disorders. The EBC estimated that the European CoI of depression was s117 billion. In Sweden, the CoI of dementia was estimated to s6.2 billion, to be compared with s4.1 billion for cancer and s3.2 for cardiovascular diseases (Wimo et al., 2007a) . Similarly, the costs of dementia in the UK have been estimated to be s29 billion per year compared to s15 and s10 billion per year for cancer and heart disease, respectively (Luengo-Fernandez et al., 2010) .
Given demographic forecasts with an increasing number of older people, and as a consequence, an increasing number of people with dementia, there is much scope for an exchange of knowledge and experience, as well as the further development of European level policy both to help promote healthy lifestyles and reduce the risk of some dementias, as well as helping to better the quality of life of both individuals with dementia and their carers.
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